Juno Bio
Juno Bio is a London-based women's health biotechnology company that sells an at-home vaginal microbiome test using next-generation sequencing to profile 45,000+ bacteria and yeast from a single swab, serving women with recurrent infections, fertility concerns, and wellness interest via direct e-commerce, subscription, and a healthcare provider channel.
- Company typePrivate
- Founded2018
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Juno Bio does
Juno Bio is a women's health biotechnology company that operates an at-home vaginal microbiome testing service targeting women and people with vaginas, particularly those experiencing recurrent infections, fertility concerns, or general wellness curiosity. The company's flagship product is the Juno Bio Vaginal Microbiome Test, an at-home kit that uses next-generation sequencing (NGS) to identify over 45,000 bacteria and yeast species from a single vaginal swab. Results include Community State Type (CST I–V) classification, microbial load analysis, identification of beneficial versus disruptive organisms, and a personalized action plan, delivered within 5–10 days via a private dashboard with 1:1 consultation from a vaginal coach. Samples are processed in a CLIA-certified high-complexity clinical laboratory (CLIA ID 05D2314895) located in Oakland, California, with results reported as clinical-grade in most US states and as wellness-only in New York, Maryland, Pennsylvania, Rhode Island, and internationally.
The company operates a direct-to-consumer e-commerce model with two principal revenue streams: a one-time test purchase at $149.00 and a subscription offering that delivers a test every three months at $99.00 (approximately 34% lower per test). A complementary channel allows registered healthcare practitioners — including naturopaths, osteopaths, nurses, pharmacists, and medical doctors — to offer Juno Bio tests directly to their clients with expert scientific interpretation support. Juno Bio also partners with Flex to enable HSA/FSA payments at checkout, providing 30–40% net savings for eligible US customers. Marketing is driven by content (an extensive educational blog), organic social (Instagram, TikTok, Facebook, X), earned media placements (Vogue, Marie Claire, TechCrunch), and the Flex partnership. The company ships to 50+ countries and has helped more than 10,000 people on their vaginal health journeys, with a 4.8/5 customer satisfaction rating across 111 verified reviews.
Juno Bio maintains a dual legal structure: Juno Bio Limited, registered in London, United Kingdom (headquarters), and Juno Bio, Inc., incorporated in Delaware, USA. The company was co-founded by Hana Janebdar (CEO, MSc) and Dr. Leighton Turner (CTO, PhD in Molecular Genetics), who lead a small team (1–10 employees) described as world-class microbiome scientists. Early-stage funding was raised in 2020 from AI Seed, Pink Salt Ventures, and Acequia Capital (AceCap); no subsequent funding rounds are disclosed in the available data. The company's stated mission is to close the gender health gap by advancing scientific understanding of the vaginal microbiome through its testing platform and aggregated anonymized research data.
Juno Bio firmographics
Firmographics- Name
- Juno Bio
- Legal name
- Juno Bio Limited
- Website
- https://juno.bio
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Juno Bio is a London-based women's health biotechnology company that sells an at-home vaginal microbiome test using next-generation sequencing to profile 45,000+ bacteria and yeast from a single swab, serving women with recurrent infections, fertility concerns, and wellness interest via direct e-commerce, subscription, and a healthcare provider channel.
- Ownership category
- akta.pro rank
Juno Bio industry classification
Industry- Product category
- Consumer Women's Health Diagnostics
- NAICS
- Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH)
- akta.pro secondary industry
- Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)
Keywords
Where Juno Bio is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Juno Bio business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Revenue model
- Single Test Purchase: One-time purchase of vaginal microbiome test kit at $149.00. Includes complete bacterial and yeast microbiome profile, free US shipping, HSA/FSA eligibility, and 1:1 consultation with vaginal coach.
- Subscription Testing: Recurring subscription model delivering one test every 3 months at $99.00 (save $50 vs single purchase). Designed for ongoing monitoring of vaginal microbiome over time. Cancel anytime after minimum of two payments.
- Gift Cards: Juno Bio Gift Card ($149.00) and Vaginal Microbiome Test Gift Card ($174.00) available for purchase as gifts.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Single Test - One-time vaginal microbiome test |
| Subscription | Annual | Subscription - Recurring 3-month testing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Juno Bio product offering
Product offeringCore offering
Juno Bio sells an at-home vaginal microbiome test kit that customers order online, self-collect via vaginal swab, and mail to a CLIA-certified lab for next-generation sequencing analysis. The company delivers a comprehensive bacterial and yeast microbiome profile (45,000+ microbes), Community State Type classification, microbial load analysis, and personalized recommendations through a private online dashboard, including a 1:1 consultation with a vaginal coach, with options for one-time purchase or a recurring 3-month subscription.
Product overview
Juno Bio offers a single primary product—the Juno Bio Vaginal Microbiome Test—alongside gift card variants. The core test is an at-home vaginal microbiome screening service using next-generation sequencing technology to provide comprehensive bacterial and yeast profiling. Results are delivered via a private dashboard with 1:1 consultation with a vaginal coach included. The company also offers gift cards for the test and a separate general gift card product.
Differentiator
Problem solved
Functional benefit
Products and services
- Juno Bio Vaginal Microbiome Test An at-home vaginal microbiome test that uses next-generation sequencing to identify over 45,000 bacteria and yeast species from a single self-collected swab. Results are delivered within 5–10 days and include Community State Type classification, a full microbiome profile, and personalized wellness recommendations along with a 1:1 consultation with a vaginal coach; designed for adult women and people with vaginas seeking personal vaginal-health insights.
- Juno Bio Gift Card A digital gift card (priced at $149.00) that grants the recipient access to Juno Bio's comprehensive at-home vaginal microbiome testing kit and detailed analysis report, delivered via email with an optional personalized message.
- Juno Bio Vaginal Microbiome Test Gift Card A dedicated gift card (priced at $174.00) specifically for the Juno Bio Vaginal Microbiome Test, granting recipients personalized vaginal health insights and a comprehensive microbial composition analysis.
Quantifiable outcome
- 10,000+ customers helped on their vaginal health journeys
- +2 more outcomes
Companies that use Juno Bio
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles2 records
Juno Bio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature4 records
Juno Bio partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- FlexcoreJuno Bio has partnered with Flex to enable customers to use their Health Savings Account (HSA) or Flexible Spending Account (FSA) to purchase vaginal microbiome tests. Flex provides an asynchronous telehealth visit as part of checkout, generating a Letter of Medical Necessity within 24 hours of purchase, enabling HSA/FSA payment and resulting in 30-40% net savings for customers.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Juno Bio competitors and assessment
Company assessmentEmerging players
- Atlas Biomed: Atlas Biomed provides D2C gut microbiome and DNA testing using NGS with personalized recommendations. Broader indication set but similar NGS-D2C model.
- Daye: UK-based vaginal health brand selling tampons, cramp care, and at-home screening. Same consumer segment with adjacent rather than overlapping microbiome testing focus.
- Jona: Jona offers D2C gut microbiome sequencing with AI-driven personalized insights. Same NGS+AI+D2C axis but broader indication than Juno Bio's current niche.
Direct peers
- Evvy: Evvy offers an at-home vaginal microbiome test using NGS with similar screening coverage and D2C positioning. Closest direct competitor to Juno Bio.
- Tiny Health: Tiny Health provides NGS-based microbiome testing for women and infants with a D2C subscription model. Targets overlapping use cases including fertility and baby microbiome.
- Viome: Viome sells D2C gut and oral microbiome tests using NGS + AI with subscription recommendations. Different indications but comparable technology and GTM motion.
- Biohm: Biohm provides gut and vaginal microbiome testing for consumers and providers with personalized probiotic recommendations. Direct overlap in vaginal microbiome and provider channel.
- Thryve: Thryve offers microbiome testing and personalized probiotics for consumers and brands. Direct overlap in microbiome sequencing services and recommendations.
Broad incumbents
- Seed Health: Seed Health develops microbiome-based probiotics with consumer products and clinical research. Adjacent rather than direct — overlapping microbiome IP rather than head-to-head testing.
- Thorne: Thorne is a large practitioner-grade supplements and at-home testing brand offering microbiome and women's health products as part of a broader portfolio rather than a vaginal specialist.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Juno Bio social profiles
Digital presenceJuno Bio compliance and trust
Trust signalCompliance1 record
Juno Bio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Juno Bio leadership team
Management profileNumber of profiles
Profiles2 records
Juno Bio funding detail
Funding detailFunding overview
Funding rounds3 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Juno Bio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Juno Bio
What does Juno Bio do?
Juno Bio sells an at-home vaginal microbiome test kit that customers order online, self-collect via vaginal swab, and mail to a CLIA-certified lab for next-generation sequencing analysis. The company delivers a comprehensive bacterial and yeast microbiome profile (45,000+ microbes), Community State Type classification, microbial load analysis, and personalized recommendations through a private online dashboard, including a 1:1 consultation with a vaginal coach, with options for one-time purchase or a recurring 3-month subscription.
Is Juno Bio a public or private company?
Juno Bio is a private company. It is classified as venture growth investor backed and is currently operating.
When was Juno Bio founded?
Juno Bio was founded in 2018. It employs 1 to 10 people.
Where is Juno Bio based?
Juno Bio is headquartered in London, United Kingdom, in the Europe region.
How does Juno Bio make money?
Three revenue lines are on record. Single Test Purchase is the primary driver. The others are subscription Testing and gift Cards.
Who are Juno Bio's main competitors?
Emerging players on record are Atlas Biomed, Daye and Jona. Direct peers are Evvy, Tiny Health, Viome, Biohm and Thryve. Broad incumbents are Seed Health and Thorne.
Does Juno Bio have an API?
No public API is recorded for Juno Bio.
What industry is Juno Bio in?
Juno Bio's product category is Consumer Women's Health Diagnostics. Its primary akta.pro industry code is HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal), with a secondary code of HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms. Its NAICS code is 621511 and its SIC code is 8071.